Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,141Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Octavius Pharma Pvt. Ltd

02 1Strides Pharma Science

03 19Gilead Sciences

04 1Orbit Lifescience

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Regulatory Info :

Registration Country : India

Sofosbuvir; Velpatasvir

Brand Name : Sofosbuvir; Velpatasvir

Dosage Form : Tablet

Dosage Strength : 400MG; 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Regulatory Info :

Registration Country : India

Sofosbuvir; Velpatasvir

Brand Name : Sofosbuvir; Velpatasvir

Dosage Form : Tablet

Dosage Strength : 400MG; 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

03

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

SOFOSBUVIR; VELPATASVIR

Brand Name : EPCLUSA

Dosage Form : TABLET;ORAL

Dosage Strength : 400MG;100MG

Packaging :

Approval Date : 2016-06-28

Application Number : 208341

Regulatory Info : RX

Registration Country : USA

blank

04

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

SOFOSBUVIR; VELPATASVIR

Brand Name : EPCLUSA

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG;50MG

Packaging :

Approval Date : 2020-03-19

Application Number : 208341

Regulatory Info : RX

Registration Country : USA

blank

05

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR

Brand Name : VOSEVI

Dosage Form : TABLET;ORAL

Dosage Strength : 400MG;100MG;100MG

Packaging :

Approval Date : 2017-07-18

Application Number : 209195

Regulatory Info : RX

Registration Country : USA

blank

06

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

SOFOSBUVIR; VELPATASVIR

Brand Name : EPCLUSA

Dosage Form : PELLETS;ORAL

Dosage Strength : 150MG;37.5MG/PACKET

Packaging :

Approval Date : 2021-06-10

Application Number : 214187

Regulatory Info : RX

Registration Country : USA

blank

07

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

SOFOSBUVIR; VELPATASVIR

Brand Name : EPCLUSA

Dosage Form : PELLETS;ORAL

Dosage Strength : 200MG;50MG/PACKET

Packaging :

Approval Date : 2021-06-10

Application Number : 214187

Regulatory Info : RX

Registration Country : USA

blank

08

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Sofosbuvir; Velpatasvir; Voxilaprevir

Brand Name : Vosevi

Dosage Form : Film Coated Tablet

Dosage Strength : 200mg;50mg;50mg

Packaging :

Approval Date : 16/09/2021

Application Number : 20200916000062

Regulatory Info : Approved

Registration Country : Sweden

blank

09

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Sofosbuvir; Velpatasvir; Voxilaprevir

Brand Name : Vosevi

Dosage Form : Film Coated Tablet

Dosage Strength : 400mg;100mg;100mg

Packaging :

Approval Date : 26/07/2017

Application Number : 20161220000066

Regulatory Info : Approved

Registration Country : Sweden

blank

10

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Sofosbuvirum; Velpatasvirum; Voxilaprevirum

Brand Name : Vosevi

Dosage Form : Film Coated Tablet

Dosage Strength : 400mg;100mg;100mg

Packaging :

Approval Date : 08/12/2017

Application Number : 66510

Regulatory Info : Allowed

Registration Country : Switzerland

blank

11

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Sofosbuvir; Velpatasvir; Voxilaprevir

Brand Name : Vosevi

Dosage Form : Film Coated Tablet

Dosage Strength : 400MG; 100MG; 100 MG

Packaging :

Approval Date : 2017-08-13

Application Number : 1171223001

Regulatory Info : Authorized

Registration Country : Spain

blank

12

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Sofosbuvir; Velpatasvir

Brand Name : Epclusa

Dosage Form : Film Coated Tablet

Dosage Strength : 400MG; 100 MG

Packaging :

Approval Date : 2025-04-14

Application Number : 1161116001IP

Regulatory Info : Authorized

Registration Country : Spain

blank

13

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Sofosbuvir; Velpatasvir

Brand Name : Epclusa

Dosage Form : Granule Coated In Sachet

Dosage Strength : 150MG; 37.5 MG

Packaging :

Approval Date : 2023-07-27

Application Number : 1161116003

Regulatory Info : Authorized

Registration Country : Spain

blank

14

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Sofosbuvir; Velpatasvir

Brand Name : Epclusa

Dosage Form : Film Coated Tablet

Dosage Strength : 400MG; 100 MG

Packaging :

Approval Date : 2016-08-02

Application Number : 1161116001

Regulatory Info : Authorized

Registration Country : Spain

blank

15

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Sofosbuvir; Velpatasvir

Brand Name : Epclusa

Dosage Form : Granule Coated In Sachet

Dosage Strength : 200MG; 50 MG

Packaging :

Approval Date : 2023-07-27

Application Number : 1161116004

Regulatory Info : Authorized

Registration Country : Spain

blank

16

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

VELPATASVIR

Brand Name : EPCLUSA

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging : 28

Approval Date :

Application Number : 2456370

Regulatory Info : Prescription

Registration Country : Canada

blank

17

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

VELPATASVIR

Brand Name : VOSEVI

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging : 28

Approval Date :

Application Number : 2467542

Regulatory Info : Prescription

Registration Country : Canada

blank

18

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

velpatasvir

Brand Name : EPCLUSA

Dosage Form : FCT

Dosage Strength : 100mg

Packaging : 28X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

19

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Sofosbuvir + velpatasvir + voxilaprevir

Brand Name : Vosevi

Dosage Form : Film-coated Tablet

Dosage Strength : 400MG

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

20

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Sofosbuvir; Velpatasvir

Brand Name : ZIFAM SOVIR VR

Dosage Form : Tablet

Dosage Strength : 400MG; 100MG

Packaging : Jar pack of 28's

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank